Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
Sara van Gennep(Amsterdam Neuroscience), Geert D’Haens(Amsterdam University Medical Centers), John Woolcott(Pfizer (United States)), Mark Löwenberg(Amsterdam University Medical Centers), D C de Jong(University Medical Center), Jitteke de Jong(Amsterdam University Medical Centers), Leonie C.S. De Vries(Amsterdam UMC Location University of Amsterdam), Aart Mookhoek(University of Bern), K Gecse(Amsterdam University Medical Centers), Esmé Clasquin(Amsterdam University Medical Centers), Rishand K Ramkisoen(Amsterdam University Medical Centers), Ivan C N Fung, Wouter J. de Jonge(University of Bonn)
Cited by 18
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865